References
- LibbyPRidkerPMHanssonGKInflammation in atherosclerosis: from pathophysiology to practiceJ Am Coll Cardiol200954232129213819942084
- ChiuJJChienSEffects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectivesPhysiol Rev201191132738721248169
- GimbroneMAGarcía-CardeñaGVascular endothelium, hemodynamics, and the pathobiology of atherosclerosisCardiovasc Pathol201322191522818581
- DamaniSBacconiALibigerOCharacterization of circulating endothelial cells in acute myocardial infarctionSci Transl Med20124126126ra33
- BurkeAPVirmaniRPathophysiology of acute myocardial infarctionMed Clin North Am2007914553572ix17640536
- FarbABurkeAPTangALCoronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary deathCirculation1996937135413638641024
- NarulaJNakanoMVirmaniRHistopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaquesJ Am Coll Cardiol201361101041105123473409
- PratiFUemuraSSouteyrandGOCT-based diagnosis and management of STEMI associated with intact fibrous capJACC Cardiovasc Imaging20136328328723473109
- YazdaniSKVorpahlMLadichEVirmaniRPathology and vulnerability of atherosclerotic plaque: identification, treatment options, and individual patient differences for prevention of strokeCurr Treat Options Cardiovasc Med201012329731420842549
- PalekarRUJalloukAPMyersonJWPanHWicklineSAInhibition of thrombin with PPACK-nanoparticles restores disrupted endothelial barriers and attenuates thrombotic risk in experimental atherosclerosisArterioscler Thromb Vasc Biol201636344645526769047
- MyersonJHeLLanzaGTollefsenDWicklineSThrombin-inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosisJ Thromb Haemost2011971292130021605330
- RidkerPMEverettBMThurenTAntiinflammatory therapy with canakinumab for atherosclerotic diseaseN Engl J Med2017377121119113128845751
- SumaraGBelwalMRicciR“JNKing” atherosclerosisCell Mol Life Sci200562212487249416231089
- MuslinAJMAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targetsClin Sci2008115720321818752467
- BogoyevitchMANgoeiKRZhaoTTYeapYYNgDCc-Jun N-terminal kinase (JNK) signaling: recent advances and challengesBiochim Biophys Acta20101804346347519900593
- RicciRSumaraGSumaraIRequirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesisScience200430657011558156115567863
- DickhoutJGBasseriSAustinRCMacrophage function and its impact on atherosclerotic lesion composition, progression, and stability: the good, the bad, and the uglyArterioscler Thromb Vasc Biol20082881413141518650503
- SinghSNarangASMahatoRISubcellular fate and off-target effects of siRNA, shRNA, and miRNAPharm Res201128122996301522033880
- FilionMCPhillipsNCToxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cellsBiochim Biophys Acta1997132923453569371426
- HuangLLiuYIn vivo delivery of RNAi with lipid-based nanoparticlesAnnu Rev Biomed Eng20111350753021639780
- GaryDJPuriNWonYYPolymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA deliveryJ Control Release20071211–2647317588702
- LvHZhangSWangBCuiSYanJToxicity of cationic lipids and cationic polymers in gene deliveryJ Control Release2006114110010916831482
- ChengJZeidanRMishraSStructure-function correlation of chloroquine and analogues as transgene expression enhancers in nonviral gene deliveryJ Med Chem200649226522653117064070
- CrombezLDivitaGA non-covalent peptide-based strategy for siRNA deliveryMethods Mol Biol201168334936021053142
- MäeMAndaloussiSELehtoTLangelUChemically modified cell-penetrating peptides for the delivery of nucleic acidsExpert Opin Drug Deliv20096111195120519831582
- HouKKPanHLanzaGMWicklineSAMelittin derived peptides for nanoparticle based siRNA transfectionBiomaterials201334123110311923380356
- HouKKPanHRatnerLSchlesingerPHWicklineSAMechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptidesACS Nano20137108605861524053333
- HouKKPanHSchlesingerPHWicklineSAA role for peptides in overcoming endosomal entrapment in siRNA delivery: a focus on melittinBiotechnol Adv201533693194026025036
- WinterPMNeubauerAMCaruthersSDEndothelial ανβ3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosisArterioscler Thromb Vasc Biol20062692103210916825592
- FengBZhangDKuriakoseGDevlinCMKockxMTabasINiemann-Pick C heterozygosity confers resistance to lesional necrosis and macrophage apoptosis in murine atherosclerosisProc Natl Acad Sci U S A200310018104231042812923293
- MyersonJWHeLAllenJSThrombin-inhibiting nanoparticles rapidly constitute versatile and detectable anticlotting surfacesNanotechnology2014253939510125200815
- PalekarRUJalloukAPGoetteMJQuantifying progression and regression of thrombotic risk in experimental atherosclerosisFASEB J20152973100310925857553
- WatersEAChenJYangXDetection of targeted perfluorocarbon nanoparticle binding using 19F diffusion weighted MR spectroscopyMagn Reson Med20086051232123618956417
- PhamCTThomasDGBeiserJApplication of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticlesNanomedicine201410365166024211337
- ZhouHFYanHPanHPeptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritisJ Clin Invest2014124104363437425157820
- WattsLTZhengWGarlingRJFrohlichVCLechleiterJDRose bengal photothrombosis by confocal optical imaging in vivo: a model of single vessel strokeJ Vis Exp2015100e5279426131664
- VicenteCPHeLPavãoMSTollefsenDMAntithrombotic activity of dermatan sulfate in heparin cofactor II-deficient miceBlood2004104133965397015315969
- WestrickRJWinnMEEitzmanDTMurine models of vascular thrombosisArterioscler Thromb Vasc Biol200727102079209317600224
- ZhangHZhangLMyersonJQuantifying the evolution of vascular barrier disruption in advanced atherosclerosis with semipermeant nanoparticle contrast agentsPLoS One2011610e2638522028868
- BlankenbergSBarbauxSTiretLAdhesion molecules and atherosclerosisAtherosclerosis2003170219120314612198
- Cuaz-PérolinCBillietLBaugéEAntiinflammatory and anti-atherogenic effects of the NF-κB inhibitor acetyl-11-keto-β-boswellic acid in LPS-challenged ApoE−/− miceArterioscler Thromb Vasc Biol200828227227718032778
- WolfrumSTeupserDTanMChenKYBreslowJLThe protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-κB target genesProc Natl Acad Sci U S A200710447186011860618006655
- FanYMaoRYangJNF-κB and STAT3 signaling pathways collaboratively link inflammation to cancerProtein Cell20134317618523483479
- GrivennikovSIKarinMDangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancerCytokine Growth Factor Rev2010211111920018552
- HeGKarinMNF-κB and STAT3: key players in liver inflammation and cancerCell Res201121115916821187858
- YuHPardollDJoveRSTATs in cancer inflammation and immunity: a leading role for STAT3Nat Rev Cancer200991179880919851315
- WangRZhangYXuLProtein inhibitor of activated STAT3 suppresses oxidized LDL-induced cell responses during atherosclerosis in apolipoprotein E-deficient miceSci Rep201663679027845432
- DutzmannJDanielJMBauersachsJHilfiker-KleinerDSeddingDGEmerging translational approaches to target STAT3 signalling and its impact on vascular diseaseCardiovasc Res2015106336537425784694
- Ait-OufellaHTalebSMallatZTedguiARecent advances on the role of cytokines in atherosclerosisArterioscler Thromb Vasc Biol201131596997921508343
- SlevinMElasbaliABTuruMKrupinskiJBadimonLGaffneyJIdentification of differential protein expression associated with development of unstable human carotid plaquesAm J Pathol200616831004102116507914
- RobbinsCSHilgendorfIWeberGFLocal proliferation dominates lesional macrophage accumulation in atherosclerosisNat Med20131991166117223933982
- MoultonKSVakiliKZurakowskiDInhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosisProc Natl Acad Sci U S A200310084736474112682294
- MoultonKSHellerEKonerdingMAFlynnEPalinskiWFolkmanJAngiogenesis inhibitors endostatin or TNP-470 reduce intimal neo-vascularization and plaque growth in apolipoprotein E-deficient miceCirculation199999131726173210190883
- BargerACBeeuwkesRLaineyLLSilvermanKJHypothesis: vasa vasorum and neovascularization of human coronary arteries – a possible role in the pathophysiology of atherosclerosisN Engl J Med198431031751776197652
- KamatBRGalliSJBargerACLaineyLLSilvermanKJNeovascularization and coronary atherosclerotic plaque: cinematographic localization and quantitative histologic analysisHum Pathol19871810103610422443438
- ZamirMSilverMDVasculature in the walls of human coronary arteriesArch Pathol Lab Med198510976596622409950
- ZhangYCliffWJSchoeflGIHigginsGImmunohistochemical study of intimal microvessels in coronary atherosclerosisAm J Pathol199314311641727686341
- SueishiKYonemitsuYNakagawaKKanedaYKumamotoMNakashimaYAtherosclerosis and angiogenesis: its pathophysiological significance in humans as well as in an animal model induced by the gene transfer of vascular endothelial growth factorAnn N Y Acad Sci199781113113249186607
- KumamotoMNakashimaYSueishiKIntimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significanceHum Pathol19952644504567535741
- PotteauxSAit-OufellaHMallatZRole of splenic monocytes in atherosclerosisCurr Opin Lipidol201526545746326270807
- HundalRSSalhBSSchraderJWGómez-MuñozADuronioVSteinbrecherUPOxidized low density lipoprotein inhibits macrophage apoptosis through activation of the PI 3-kinase/PKB pathwayJ Lipid Res20014291483149111518769
- MatsumuraTSakaiMKoboriSTwo intracellular signaling pathways for activation of protein kinase C are involved in oxidized low-density lipoprotein-induced macrophage growthArterioscler Thromb Vasc Biol19971711301330209409288
- BiwaTHakamataHSakaiMInduction of murine macrophage growth by oxidized low density lipoprotein is mediated by granulocyte macrophage colony-stimulating factorJ Biol Chem19982734328305283139774454
- SakaiMMiyazakiAHakamataHLysophosphatidylcholine potentiates the mitogenic activity of modified LDL for human monocyte-derived macrophagesArterioscler Thromb Vasc Biol19961646006058624783
- WangMSubramanianMAbramowiczSInterleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiencyArterioscler Thromb Vasc Biol201434597698424651678
- MooreKJSheedyFJFisherEAMacrophages in atherosclerosis: a dynamic balanceNat Rev Immunol2013131070972123995626
- LiJLeyKLymphocyte migration into atherosclerotic plaqueArterioscler Thromb Vasc Biol2015351404925301842
- YanHDuanXPanHSuppression of NF-κB activity via nanoparticle-based siRNA delivery alters early cartilage responses to injuryProc Natl Acad Sci U S A201611341E6199E620827681622
- KantersEPasparakisMGijbelsMJInhibition of NF-κB activation in macrophages increases atherosclerosis in LDL receptor-deficient miceJ Clin Invest200311281176118514561702
- PoberJSMinWBradleyJRMechanisms of endothelial dysfunction, injury, and deathAnnu Rev Pathol20094719518754744
- DurandEScoazecALafontAIn vivo induction of endothelial apoptosis leads to vessel thrombosis and endothelial denudation: a clue to the understanding of the mechanisms of thrombotic plaque erosionCirculation2004109212503250615148270
- GrassetEKDuhlinAAgardhHESterile inflammation in the spleen during atherosclerosis provides oxidation-specific epitopes that induce a protective B-cell responseProc Natl Acad Sci U S A201511216E2030E203825848033
- SwirskiFKNahrendorfMLeukocyte behavior in atherosclerosis, myocardial infarction, and heart failureScience2013339611616116623307733